NASDAQ:ICLR - Icon Stock Price, Price Target & More

Icon trades on the NASDAQ under the ticker symbol "ICLR."

Icon Plc (NASDAQ:ICLR) announced its earnings results on Thursday, May, 3rd. The medical research company reported $1.42 earnings per share for the quarter, beating the consensus estimate of $1.41 by $0.01. The medical research company earned $620.13 million during the quarter, compared to the consensus estimate of $562.61 million. Icon had a net margin of 14.80% and a return on equity of 26.56%. The firm's revenue for the quarter was up 43.6% on a year-over-year basis. During the same quarter in the previous year, the company posted $1.29 EPS. View Icon's Earnings History.

Icon is scheduled to release their next quarterly earnings announcement on Thursday, July, 26th 2018. View Earnings Estimates for Icon.

Icon issued an update on its FY18 earnings guidance on Wednesday, May, 2nd. The company provided earnings per share guidance of $5.91-6.11 for the period, compared to the Thomson Reuters consensus EPS estimate of $5.99. The company issued revenue guidance of $2.52-2.64 billion, compared to the consensus revenue estimate of $2.25 billion.

10 brokerages have issued 12 month target prices for Icon's shares. Their predictions range from $114.00 to $152.00. On average, they anticipate Icon's share price to reach $130.70 in the next twelve months. View Analyst Ratings for Icon.

Some companies that are related to Icon include Iqvia (IQV), Incyte (INCY), EXACT Sciences (EXAS), PRA Health Sciences (PRAH), Exelixis (EXEL), Charles River Laboratories Intl. (CRL), Syneos Health (SYNH), BTG (BTGGF), Intrexon (XON), Medpace (MEDP), National Research (NRCIB), National Research (NRCIA), Sorrento Therapeutics (SRNE), Eloxx Pharmaceuticals (ELOX) and Pieris Pharmaceuticals (PIRS).

News stories about ICLR stock have trended somewhat positive this week, according to Accern Sentiment Analysis. The research firm identifies negative and positive media coverage by analyzing more than 20 million blog and news sources in real-time. Accern ranks coverage of publicly-traded companies on a scale of -1 to 1, with scores closest to one being the most favorable. Icon earned a news sentiment score of 0.09 on Accern's scale. They also assigned media stories about the medical research company an impact score of 45.67 out of 100, meaning that recent media coverage is somewhat unlikely to have an effect on the company's share price in the next few days.

Icon's stock is owned by a number of of institutional and retail investors. Top institutional shareholders include WCM Investment Management CA (8.25%), Earnest Partners LLC (4.01%), Wasatch Advisors Inc. (3.07%), Boston Partners (3.01%), Wells Fargo & Company MN (1.93%) and Principal Financial Group Inc. (1.75%). View Institutional Ownership Trends for Icon.

ICLR stock was sold by a variety of institutional investors in the last quarter, including Westfield Capital Management Co. LP, Earnest Partners LLC, Envestnet Asset Management Inc., Wasatch Advisors Inc., Victory Capital Management Inc., Fiera Capital Corp, Wells Fargo & Company MN and Loomis Sayles & Co. L P. View Insider Buying and Selling for Icon.

ICLR stock was purchased by a variety of institutional investors in the last quarter, including Boston Partners, WCM Investment Management CA, Principal Financial Group Inc., Principal Financial Group Inc., Lord Abbett & CO. LLC, Massachusetts Financial Services Co. MA, American Century Companies Inc. and Baird Financial Group Inc.. View Insider Buying and Selling for Icon.

Shares of ICLR can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

One share of ICLR stock can currently be purchased for approximately $137.03.

Icon has a market capitalization of $7.37 billion and generates $1.76 billion in revenue each year. The medical research company earns $281.48 million in net income (profit) each year or $5.39 on an earnings per share basis. Icon employs 13,250 workers across the globe.

Icon's mailing address is SOUTH COUNTY BUSINESS PARK LEOPARDSTOWN, DUBLIN L2, 00000. The medical research company can be reached via phone at 353-1291-2000.